Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
FDA Approves EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyTotal Revenue $19...
Day: April 9, 2025
Beta Bionics to Host Investor Event on June 22, 2025
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the...
Mars Veterinary Health Underscores Long-Term Commitment to Research & Innovation in Groundbreaking Science Impact Report
Global leader in peer-reviewed veterinary research highlights progress in advancing veterinary science and clinical excellence through inaugural science report launch...
Preliminary results for the year ended 31 December 2024
~ Strong commercial momentum underpins transformative financial performance ~ Strong 2024 financial performance in line with guidance Revenue growth of...
Atea Pharmaceuticals Announces Dosing of First Patient in C-BEYOND, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
Regimen has Potential Best-in-Class Profile with Short Treatment Duration, Low Risk for Drug-Drug Interactions and Convenience with No Food Effect...
American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub
Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- American...
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing...
Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
Agreement includes the use of Tonix’s TNX-1500, as part of an immunomodulatory regimen to reduce rejection of Makana’s genetically engineered...
Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of Its Alcohol Detox Beverage unbuzzd
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - Celly Nutrition Corporation (the "Company" or "Celly Nutrition"), the company behind...
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET
PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that...
Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025
ORION CORPORATION PRESS RELEASE 9 APRIL 2025 at 13.30 EEST Orion publishes Interim Report for January–March 2025 and holds...
Coave Therapeutics to Attend Upcoming Conferences
Paris, France, April 9, 2025 – Coave Therapeutics (‘Coave’), a company pioneering the future of genetic medicines, announces that members...
Emirati Women Chapter Onboards Second Cohort of 62 Participants
Under the patronage of H.H. Sheikha Fatima bint MubarakABU DHABI, United Arab Emirates, April 09, 2025 (GLOBE NEWSWIRE) -- Under...
Barbara Weber, M.D., Elected to ITM Supervisory Board
Barbara Weber, M.D., Elected to ITM Supervisory Board Headshot Barbara Weber, M.D. Garching / Munich, Germany, April 09, 2025 –...
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
Phase 2 to evaluate safety, tolerability and efficacy of INNA-051 in the prevention of illness due to viral respiratory infectionsStudy...
SBC Medical to Present at the Emerging Growth Conference on April 17, 2025
SBC Medical Group Holdings Incorporated invites individual and institutional investors as well as advisors and analysts, to attend its real-time,...
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO
HELSINKI and NAPLES, Italy, April 09, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), an immunotherapy company developing novel, adaptable...
Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer
New CCO Joins as Cytosurge Engages in Key Scientific Events Across the USA and BeyondZURICH, Switzerland, April 09, 2025 (GLOBE...
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in...
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from Phase 2 Extension Period...